Acquired by ResMed VirtuOx was acquired by ResMed in May 2025, signaling a potential opportunity to align with a larger distribution and integration network in home health and sleep diagnostics.

Home Diagnostics Scale With over 40,000+ new diagnostic tests monthly conducted in patients’ homes and a range of services (POX, HSAT, EEG insomnia testing, MCT, RPM), there is a broad landscape for upsell partnerships, device integrations, and expanded home-based monitoring solutions.

Sleep and Dental Recent launch of Sleepifi Dental complements existing sleep diagnostics and opens cross-sell opportunities with dental sleep medicine providers, enabling joint workflows, billing, and data sharing with dental practices and sleep clinics.

Regulatory & Compliance As a Joint Commission approved and Medicare certified IDTF, VirtuOx emphasizes quality and compliance; sales conversations can emphasize certified pathways, reimbursement readiness, and risk reduction for providers and homecare networks.

Financial Scope Revenue range of 25–50 million with 51–200 employees indicates a midsize, revenue-friendly partner, suggesting viability for value-based service offerings, device provisioning, data analytics, and integrated care platforms that support scale.